Ontology highlight
ABSTRACT: Summary
In the face of many unknowns (i.e., transmission, symptomology) posed by the unprecedented 2022-2023 mpox epidemic, near real-time short-term forecasts of the epidemic's trajectory were essential in intervention implementation and guiding policy. As case levels continue to dissipate, evaluating the modeling strategies used in producing real-time forecasts is critical to refine and grow the field of epidemiological forecasting. Here, we systematically evaluate the performance of an ensemble n -sub-epidemic and related sub-epidemic wave (spatial-wave) modeling frameworks against ARIMA, GAM, Prophet, and SLR models in producing sequential retrospective weekly (1-4 week) forecasts of mpox cases for the highest burdened countries (i.e., Brazil, Canada, France, Germany, Spain, the United Kingdom, and the United States) and on a global scale. Overall, the n -sub-epidemic framework outperformed all other models most frequently, followed closely in success by the spatial-wave framework, GAM, and ARIMA models regarding average MSE, MAE, and WIS metrics. The n -sub-epidemic unweighted model and spatial-wave framework performed best overall based on average 95% PI coverage, and we noted widespread success for both frameworks in average Winkler scores. The considerable success seen with both frameworks highlights the continued utility of sub-epidemic methodologies in producing short-term forecasts and their potential application to other epidemiologically different diseases.
SUBMITTER: Bleichrodt A
PROVIDER: S-EPMC10615009 | biostudies-literature | 2023 Oct
REPOSITORIES: biostudies-literature
medRxiv : the preprint server for health sciences 20231017
In May 2022, public health officials noted an unprecedented surge in mpox cases in non-endemic countries worldwide. As the epidemic accelerated, multi-model forecasts of the epidemic's trajectory were critical in guiding the implementation of public health interventions and determining policy. As the case levels have significantly decreased as of early September 2022, evaluating model performance is essential to advance the growing field of epidemic forecasting. Using laboratory-confirmed mpox c ...[more]